153 related articles for article (PubMed ID: 37675782)
1. Paradoxical Expression of R-10G-reactive Antigen in Human Testicular Embryonal Carcinoma.
Muramoto A; Inamura S; Hoshino H; Terada N; Kobayashi M
J Histochem Cytochem; 2023 Oct; 71(10):555-563. PubMed ID: 37675782
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
3. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
Lau SK; Weiss LM; Chu PG
Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
[TBL] [Abstract][Full Text] [Related]
4. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
[TBL] [Abstract][Full Text] [Related]
5. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
6. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.
Badcock G; Pigott C; Goepel J; Andrews PW
Cancer Res; 1999 Sep; 59(18):4715-9. PubMed ID: 10493530
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and biochemical characterisation of the expression of a human embryonal carcinoma cell proteoglycan antigen in human germ cell tumours and other tissues.
Mason MD; Pera MF
Eur J Cancer; 1992; 28A(6-7):1090-8. PubMed ID: 1320911
[TBL] [Abstract][Full Text] [Related]
8. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Int J Androl; 1998 Oct; 21(5):283-8. PubMed ID: 9805244
[TBL] [Abstract][Full Text] [Related]
10. A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures.
Kawabe K; Tateyama D; Toyoda H; Kawasaki N; Hashii N; Nakao H; Matsumoto S; Nonaka M; Matsumura H; Hirose Y; Morita A; Katayama M; Sakuma M; Kawasaki N; Furue MK; Kawasaki T
Glycobiology; 2013 Mar; 23(3):322-36. PubMed ID: 23154990
[TBL] [Abstract][Full Text] [Related]
11. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma.
Leroy X; Augusto D; Leteurtre E; Gosselin B
J Histochem Cytochem; 2002 Feb; 50(2):283-5. PubMed ID: 11799147
[TBL] [Abstract][Full Text] [Related]
12. Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression.
Miyai K; Ito K; Nakanishi K; Tsuda H
Virchows Arch; 2019 Jun; 474(6):711-720. PubMed ID: 30877382
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
[TBL] [Abstract][Full Text] [Related]
14. Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity.
Mueller T; Mueller LP; Holzhausen HJ; Witthuhn R; Albers P; Schmoll HJ
Histochem Cell Biol; 2010 Aug; 134(2):197-204. PubMed ID: 20532795
[TBL] [Abstract][Full Text] [Related]
15. Nuclear lamin expression in normal testis and testicular germ cell tumours of adolescents and adults.
Machiels BM; Ramaekers FC; Kuijpers HJ; Groenewoud JS; Oosterhuis JW; Looijenga LH
J Pathol; 1997 Jun; 182(2):197-204. PubMed ID: 9274531
[TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
17. TRA-1-60: a new serum marker in patients with germ-cell tumors.
Marrink J; Andrews PW; van Brummen PJ; de Jong HJ; Sleijfer DT; Schraffordt Koops H; Oosterhuis JW
Int J Cancer; 1991 Sep; 49(3):368-72. PubMed ID: 1717384
[TBL] [Abstract][Full Text] [Related]
18. CA19-9: a possible serum marker for embryonal carcinoma.
Tsuruta T; Ogawa A; Ishii K; Ikado S
Urol Int; 1997; 58(1):20-4. PubMed ID: 9058515
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer.
Lajer H; Daugaard G; Andersson AM; Skakkebaek NE
Int J Cancer; 2002 Jul; 100(2):244-6. PubMed ID: 12115576
[TBL] [Abstract][Full Text] [Related]
20. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
